Pharvision Advisers, LLC / TKC
Pharvision Advisers, LLC’s Turkcell Iletisim Position
Does Pharvision Advisers, LLC own Turkcell Iletisim (TKC)? Yes — 18.8K shares worth $113,262 (+1.15% of its 13F portfolio) as of Q1 2026, up from 18.5K shares the prior filed quarter.
Position Value
$113,262
Q1 2026
Shares
18.8K
% of Portfolio
+1.15%
Quarters Held
2
currently held
Position History TKC
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Pharvision Advisers, LLC’s full portfolio or all institutional holders of TKC.